A spectroscopic approach to lipoprotein subclass analysis

Journal of Clinical Ligand Assay

Volumn 19, Issue 3, 1996, Pages 184-189

  Otvos, James ^a   Jeyarajah, Elias ^a   Bennett, Dennis ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Coronary disease; Lipoproteins; NMR

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; REVIEW; RISK ASSESSMENT; SPECTROSCOPY;

EID: 0030513719     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Nestel PJ: The regulation of lipoprotein metabolism, in Gotto AM (ed): Plasma Lipoproteins. Amsterdam, Elsevier, Amsterdam, 1987, pp 153-182.
2. Musliner TA, Krauss RM: Lipoprotein subspecies and risk of coronary disease. Clin Chem 1988;34(Suppl):B78-83.
3. Austin MA, Breslow JL, Hennekens CH, et al: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921.
4. Griffin BA, Freeman DJ, Tait GW, et al: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-253.
5. Campos H, Genest JJ, Blijlevens E, et al: Low density particle size and coronary artery disease. Arterioscler Thromb 1992;12:187-195.
6. Gardner CD, Fortman SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-881.
7. Stampfer MJ, Krauss RM, Ma J, et al: A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-888.
8. Wilson HM, Patel JC, Russe D, et al: Alterations in the concentration of an apolipoprotein E-containing subfraction of plasma high density lipoprotein in coronary heart disease. Clin Chim Acta 1993;220:175-187.
9. Johansson J, Carlson LA, Landou C, et al: High-density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991;11:174-182.
10. Working Group on Lipoprotein Measurement: NCEP recommendations on lipoprotein measurement. NIH Publication No. 95-3044, 1995.
11. Otvos JD, Jeyarajah EJ, Bennett DW: Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991;37:377-386.
12. Otvos JD, Jeyarajah EJ, Bennett DW, et al: Development of aproton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 1992;38:1632-1638.
13. Otvos JD: Determination of lipoproteins and their subfractions by nuclear magnetic resonance, in Rifai N and Warnick GR (eds):. Laboratory Measurement of Lipids, Lipoproteins, and Apolipoproteins. Washington, D.C., AACC Press, 1994, pp 329-333.
14. Lounila J, Ala-Korpela M, Jokisaari J: Effects of orientational order and particle size on the NMR line positions of lipoproteins. Phys Rev 1994;72:4049-4052.
15. Belcher JD, McNamara JR, Grinstead GF, et al: Measurement of low-density lipoprotein cholesterol concentration, in Rifai N and Warnick GR (eds): Laboratory Measurement of Lipids, Lipoproteins, and Apolipoproteins. Washington, D.C., AACC Press, 1994, pp 107-123.
16. Krauss RM, Blanche PJ: Detection and quantitation of LDL subfractions. Current Opinion in Lipidology 1992;3:377-383.
17. Blanche PJ, Gong EL, Forte TM, et al: Characterization of the human high-density lipoproteins by gradient gel electrophoresis. Biochem Biophys Acta 1981;665:408-419.
18. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 1993;34:1255-1274.
19. Dreon DM, Fernstrom HA, Miller B, et al: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 1994;8:121-126.
20. Miller BD, Alderman EL, Haskell WL, et al: Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford coronary risk intervention project. Circulation 1996;94:2146-2153.
21. Superko HR: Beyond LDL cholesterol reduction. Circulation 1996;2351-2354.
22. Austin MA, King MC, Vranizan KM, et al: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
23. McNamara JR, Jenner JL, Li Z, et al: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-1290.
24. Coresh J, Kwiterovich PO: Small, dense low-density lipoprotein particles and coronary heart disease risk: a clear association with uncertain implications. JAMA 1996;276:914-915.